Atyr Pharma Inc (ATYR)

$0.56 +0.02 (4.54%)
Market Cap 46.10M
Revenue (ttm) 190,000.00
Net Income (ttm) -74.12M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -39,010.53%
Debt to Equity Ratio 0.00
Volume 3,639,600
Avg Vol 2,645,694
Day's Range N/A - N/A
Shares Out 98.05M
Stochastic %K 81%
Beta 0.55
Analysts Sell
Price Target $2.75

Company Profile

aTyr Pharma, Inc., a clinical stage biotechnology company, engages in the discovery and development of product candidates that translate tRNA synthetase biology into new therapies for fibrosis and inflammation in the United States. Its lead therapeutic candidate efzofitimod, a selective modulator of NRP2 that is in Phase 3 clinical trial for the treatment of pulmonary sarcoidosis; Phase 2 clinical trial to treat Sarcoidosis and systemic sclerosis- interstitial lung disease (ILDs); and treatment...

Industry: Biotechnology
Sector: Healthcare
Phone: 858 731 8389
Fax: 858 731 8394
Address:
10240 Sorrento Valley Road, Suite 300, San Diego, United States
Wallace911
Wallace911 Jun. 24 at 6:32 PM
$ATYR let's go Atyr for the 1$
0 · Reply
mido89
mido89 Jun. 24 at 6:16 PM
$ATYR should we add more here, i have 20,000 shares
0 · Reply
Tinhuynh789
Tinhuynh789 Jun. 24 at 6:10 PM
$ATYR all in
0 · Reply
stefano62
stefano62 Jun. 24 at 2:04 PM
$ATYR direction 1$ has been take. If they Will maintain the promise tò submit the new IND within end of june
0 · Reply
ElToroDeTomorrow
ElToroDeTomorrow Jun. 24 at 8:43 AM
$ATYR
0 · Reply
MilkingAlgosEveryMonday
MilkingAlgosEveryMonday Jun. 23 at 10:03 PM
$OTLK $ATYR $VG one of best day so far in the stock market!
1 · Reply
LewisDaKat
LewisDaKat Jun. 23 at 9:30 PM
$ATYR Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th https://marketwirenews.com/stock/atyr/news/life-sciences-virtual-investor-forum-agenda-announce-7012955047856155.html?utm_source=stocktwits
0 · Reply
X600X
X600X Jun. 23 at 9:16 PM
$ATYR we will see🤩
0 · Reply
SpartanTrader117
SpartanTrader117 Jun. 23 at 8:53 PM
$ATYR
0 · Reply
topstockalerts
topstockalerts Jun. 23 at 7:50 PM
$ATYR the buyers showed up exactly when they needed to.
0 · Reply
Latest News on ATYR
aTyr Pharma Transcript: Jefferies Global Healthcare Conference 2026

Jun 4, 2026, 3:45 PM EDT - 20 days ago

aTyr Pharma Transcript: Jefferies Global Healthcare Conference 2026

Forget the SpaceX IPO. These 2 New Stocks Stand Out Right Now.

May 26, 2026, 3:08 PM EDT - 4 weeks ago

Forget the SpaceX IPO. These 2 New Stocks Stand Out Right Now.

LIFE PTRN

Ethos Partners with Baseball Legend David Ortiz to Champion Life Insurance as a Family Financial Essential

May 21, 2026, 9:07 AM EDT - 4 weeks ago

Ethos Partners with Baseball Legend David Ortiz to Champion Life Insurance as a Family Financial Essential

LIFE

aTyr Pharma upgraded to Buy from Hold at Freedom Broker

2026-05-20T13:00:12.000Z - 5 weeks ago

aTyr Pharma upgraded to Buy from Hold at Freedom Broker

Ethos to Present at Upcoming Investor Conferences

May 15, 2026, 4:30 PM EDT - 5 weeks ago

Ethos to Present at Upcoming Investor Conferences

LIFE

aTyr Pharma reports Q1 EPS (11c), consensus (15c)

2026-05-15T15:42:31.000Z - 5 weeks ago

aTyr Pharma reports Q1 EPS (11c), consensus (15c)

aTyr Pharma Announces First Quarter 2026 Results and Provides Corporate Update

May 15, 2026, 8:00 AM EDT - 5 weeks ago

aTyr Pharma Announces First Quarter 2026 Results and Provides Corporate Update

aTyr Pharma Quarterly report: Q1 2026

May 15, 2026, 7:00 AM EDT - 5 weeks ago

aTyr Pharma Quarterly report: Q1 2026

aTyr Pharma Earnings release: Q1 2026

May 15, 2026, 7:00 AM EDT - 5 weeks ago

aTyr Pharma Earnings release: Q1 2026

Ethos Announces Early Lock-Up Release

May 13, 2026, 4:35 PM EDT - 6 weeks ago

Ethos Announces Early Lock-Up Release

LIFE

aTyr Pharma to Participate in Upcoming Investor Conferences

May 13, 2026, 4:01 PM EDT - 6 weeks ago

aTyr Pharma to Participate in Upcoming Investor Conferences

aTyr Pharma provides regulatory update on efzofitimod following Type C meeting

2026-05-11T23:05:03.000Z - 6 weeks ago

aTyr Pharma provides regulatory update on efzofitimod following Type C meeting

aTyr Pharma Transcript: Study update

May 11, 2026, 4:30 PM EDT - 6 weeks ago

aTyr Pharma Transcript: Study update

aTyr Pharma Press release: Study update

May 11, 2026, 4:30 PM EDT - 6 weeks ago

aTyr Pharma Press release: Study update

aTyr Pharma Slides: Study update

May 11, 2026, 4:30 PM EDT - 6 weeks ago

aTyr Pharma Slides: Study update

aTyr Pharma Provides Regulatory and Clinical Update for Efzofitimod in Pulmonary Sarcoidosis Following FDA Type C Meeting

May 11, 2026, 4:01 PM EDT - 6 weeks ago

aTyr Pharma Provides Regulatory and Clinical Update for Efzofitimod in Pulmonary Sarcoidosis Following FDA Type C Meeting

Ethos Reports First Quarter Fiscal Year 2026 Financial Results

May 6, 2026, 4:05 PM EDT - 7 weeks ago

Ethos Reports First Quarter Fiscal Year 2026 Financial Results

LIFE

Ethos Launches ChatGPT App To Bring Instant Life Insurance Estimates to 900 Million Users

May 5, 2026, 9:07 AM EDT - 7 weeks ago

Ethos Launches ChatGPT App To Bring Instant Life Insurance Estimates to 900 Million Users

LIFE

Ethos Collaborates with Liberty Mutual to Deliver a Modern, Digital-First Life Insurance Experience

Apr 23, 2026, 9:07 AM EDT - 2 months ago

Ethos Collaborates with Liberty Mutual to Deliver a Modern, Digital-First Life Insurance Experience

LIFE

Ethos to Announce First Quarter 2026 Financial Results on May 6, 2026

Apr 2, 2026, 4:05 PM EDT - 2 months ago

Ethos to Announce First Quarter 2026 Financial Results on May 6, 2026

LIFE

aTyr Pharma Proxy statement: Proxy filing

Mar 26, 2026, 8:00 AM EDT - 3 months ago

aTyr Pharma Proxy statement: Proxy filing

aTyr Pharma Proxy statement: Proxy filing

Mar 26, 2026, 8:00 AM EDT - 3 months ago

aTyr Pharma Proxy statement: Proxy filing

Ethos and Banner Life Expand Offering to Bring Final Expense Coverage to More Families

Mar 24, 2026, 4:05 PM EDT - 3 months ago

Ethos and Banner Life Expand Offering to Bring Final Expense Coverage to More Families

LIFE

aTyr Pharma Proxy statement: Proxy Filing

Mar 12, 2026, 8:00 AM EDT - 3 months ago

aTyr Pharma Proxy statement: Proxy Filing

aTyr Pharma Transcript: Leerink Global Healthcare Conference 2026

Mar 11, 2026, 8:00 AM EDT - 3 months ago

aTyr Pharma Transcript: Leerink Global Healthcare Conference 2026

aTyr Pharma reports Q4 EPS (14c), consensus (17c)

2026-03-05T21:05:56.000Z - 3 months ago

aTyr Pharma reports Q4 EPS (14c), consensus (17c)

aTyr Pharma Announces Fourth Quarter and Full Year 2025 Results and Provides Corporate Update

Mar 5, 2026, 4:01 PM EST - 3 months ago

aTyr Pharma Announces Fourth Quarter and Full Year 2025 Results and Provides Corporate Update

aTyr Pharma Annual report: Q4 2025

Mar 5, 2026, 3:00 PM EST - 3 months ago

aTyr Pharma Annual report: Q4 2025

aTyr Pharma Earnings release: Q4 2025

Mar 5, 2026, 3:00 PM EST - 3 months ago

aTyr Pharma Earnings release: Q4 2025

Ethos to Participate in The Citizens Technology Conference

Feb 26, 2026, 4:06 PM EST - 4 months ago

Ethos to Participate in The Citizens Technology Conference

LIFE

Ethos Reports Fourth Quarter and Fiscal Year 2025 Financial Results

Feb 25, 2026, 4:05 PM EST - 4 months ago

Ethos Reports Fourth Quarter and Fiscal Year 2025 Financial Results

LIFE

aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Feb 20, 2026, 4:01 PM EST - 4 months ago

aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

aTyr Pharma to Present at the Leerink Partners Global Healthcare Conference

Feb 18, 2026, 8:00 AM EST - 4 months ago

aTyr Pharma to Present at the Leerink Partners Global Healthcare Conference

Ethos to Announce Fourth Quarter 2025 Financial Results on February 25, 2026

Feb 5, 2026, 4:05 PM EST - 4 months ago

Ethos to Announce Fourth Quarter 2025 Financial Results on February 25, 2026

LIFE

The IPO Market Faces a Busy Week. These Stocks Are Making Their Debuts.

Feb 3, 2026, 2:46 PM EST - 5 months ago

The IPO Market Faces a Busy Week. These Stocks Are Making Their Debuts.

FPS LFTO YSS

aTyr Pharma announces U.S. FDA accepted meeting request for efzofitimod

2026-02-03T13:10:35.000Z - 5 months ago

aTyr Pharma announces U.S. FDA accepted meeting request for efzofitimod

aTyr Pharma Announces Scheduling of FDA Type C Meeting to Discuss Efzofitimod Program in Pulmonary Sarcoidosis

Feb 3, 2026, 8:00 AM EST - 5 months ago

aTyr Pharma Announces Scheduling of FDA Type C Meeting to Discuss Efzofitimod Program in Pulmonary Sarcoidosis

Insurance platform Ethos Technologies valued at $1.2 billion in Nasdaq debut

Jan 29, 2026, 12:30 PM EST - 5 months ago

Insurance platform Ethos Technologies valued at $1.2 billion in Nasdaq debut

Ethos Announces Pricing of Initial Public Offering

Jan 28, 2026, 10:38 PM EST - 5 months ago

Ethos Announces Pricing of Initial Public Offering

Ethos Technologies prices US IPO at $19/share, Bloomberg News reports

Jan 28, 2026, 9:05 PM EST - 5 months ago

Ethos Technologies prices US IPO at $19/share, Bloomberg News reports

Ethos and North American Collaborate to Offer Accumulation Indexed Universal Life Product

Jan 7, 2026, 8:01 AM EST - 6 months ago

Ethos and North American Collaborate to Offer Accumulation Indexed Universal Life Product

Ethos and Aflac Partner to Bring Supplemental Health Product Suite to Independent Distribution

Dec 18, 2025, 8:01 AM EST - 6 months ago

Ethos and Aflac Partner to Bring Supplemental Health Product Suite to Independent Distribution

Johnson Fistel Investigates Claims on Behalf of aTyr Pharma, Inc. (ATYR) Shareholders

Dec 15, 2025, 2:45 PM EST - 6 months ago

Johnson Fistel Investigates Claims on Behalf of aTyr Pharma, Inc. (ATYR) Shareholders

aTyr Pharma, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - ATYR

Dec 8, 2025, 3:25 AM EST - 7 months ago

aTyr Pharma, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - ATYR

aTyr Pharma Transcript: Piper Sandler 37th Annual Healthcare Conference

Dec 2, 2025, 1:00 PM EST - 7 months ago

aTyr Pharma Transcript: Piper Sandler 37th Annual Healthcare Conference

aTyr Pharma Faces Class Action after Clinical Trial Failure Raises Investor Concerns

2025-11-25T15:09:57.000Z - 7 months ago

aTyr Pharma Faces Class Action after Clinical Trial Failure Raises Investor Concerns

aTyr Pharma reports Q3 EPS (26c), consensus (18c)

2025-11-06T21:26:32.000Z - 8 months ago

aTyr Pharma reports Q3 EPS (26c), consensus (18c)

aTyr Pharma Earnings release: Q3 2025

Nov 6, 2025, 4:00 PM EST - 8 months ago

aTyr Pharma Earnings release: Q3 2025

aTyr Pharma Quarterly report: Q3 2025

Nov 6, 2025, 4:00 PM EST - 8 months ago

aTyr Pharma Quarterly report: Q3 2025

aTyr Pharma reports clinical benefit for efzofitimod across multiple diseases

2025-09-30T10:20:48.000Z - 9 months ago

aTyr Pharma reports clinical benefit for efzofitimod across multiple diseases

Piper Sandler healthcare analysts hold an analyst/industry conference call

2025-09-29T20:40:08.000Z - 9 months ago

Piper Sandler healthcare analysts hold an analyst/industry conference call

aTyr Pharma downgraded to Sector Perform from Outperform at RBC Capital

2025-09-15T20:30:25.000Z - 10 months ago

aTyr Pharma downgraded to Sector Perform from Outperform at RBC Capital

Wells Fargo downgrades aTyr Pharma on efzofitimod Phase 3 failure

2025-09-15T18:00:09.000Z - 10 months ago

Wells Fargo downgrades aTyr Pharma on efzofitimod Phase 3 failure

Wallace911
Wallace911 Jun. 24 at 6:32 PM
$ATYR let's go Atyr for the 1$
0 · Reply
mido89
mido89 Jun. 24 at 6:16 PM
$ATYR should we add more here, i have 20,000 shares
0 · Reply
Tinhuynh789
Tinhuynh789 Jun. 24 at 6:10 PM
$ATYR all in
0 · Reply
stefano62
stefano62 Jun. 24 at 2:04 PM
$ATYR direction 1$ has been take. If they Will maintain the promise tò submit the new IND within end of june
0 · Reply
ElToroDeTomorrow
ElToroDeTomorrow Jun. 24 at 8:43 AM
$ATYR
0 · Reply
MilkingAlgosEveryMonday
MilkingAlgosEveryMonday Jun. 23 at 10:03 PM
$OTLK $ATYR $VG one of best day so far in the stock market!
1 · Reply
LewisDaKat
LewisDaKat Jun. 23 at 9:30 PM
$ATYR Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th https://marketwirenews.com/stock/atyr/news/life-sciences-virtual-investor-forum-agenda-announce-7012955047856155.html?utm_source=stocktwits
0 · Reply
X600X
X600X Jun. 23 at 9:16 PM
$ATYR we will see🤩
0 · Reply
SpartanTrader117
SpartanTrader117 Jun. 23 at 8:53 PM
$ATYR
0 · Reply
topstockalerts
topstockalerts Jun. 23 at 7:50 PM
$ATYR the buyers showed up exactly when they needed to.
0 · Reply
Aldinho_lbk
Aldinho_lbk Jun. 23 at 7:28 PM
$ATYR today we break the 5Y average volume of 2.34M shares traded ... 2.64M shares is the current volume. Lets keep it up!!!.
1 · Reply
X600X
X600X Jun. 23 at 7:10 PM
$ATYR $SLS Buy or cry later
2 · Reply
X600X
X600X Jun. 23 at 7:08 PM
$ATYR buy the Dip
0 · Reply
X600X
X600X Jun. 23 at 7:02 PM
$SLS $RDW $ATYR
0 · Reply
Homer_Simpson82
Homer_Simpson82 Jun. 23 at 6:17 PM
$ATYR next pump and dumping
0 · Reply
X600X
X600X Jun. 23 at 6:00 PM
$SLS $ATYR
0 · Reply
mido89
mido89 Jun. 23 at 5:58 PM
$ATYR waiting to see the 1$ soon 🚀
1 · Reply
SilentJoker34
SilentJoker34 Jun. 23 at 5:46 PM
$OTLK $ATYR
1 · Reply
AtariLynx
AtariLynx Jun. 23 at 5:22 PM
$ATYR There's no particular news. My fear is Atyr do what PICARD MEDICAL did a few weeks ago. Just pump, few crazy days, and then go back to the values ​​of the last month. Hope i’m wrong.
1 · Reply
Wallace911
Wallace911 Jun. 23 at 5:04 PM
$ATYR let’s go for The 1$
0 · Reply
Wallace911
Wallace911 Jun. 23 at 4:48 PM
$ATYR what’s happen ?
0 · Reply
X600X
X600X Jun. 23 at 4:47 PM
$ATYR let's go...
0 · Reply